Effects of tempol and candesartan on neural control of the kidney

Gabriela A Eppel1, Geoffrey A Head, Kate M Denton

  • 1Department of Physiology, Monash University, Melbourne, Australia.

Insights

Tempol did not affect renal nerve stimulation responses, unlike candesartan. Superoxide plays a minor role in angiotensin II

Area of Science:

  • Nephrology
  • Pharmacology
  • Physiology

Background:

  • The role of superoxide and angiotensin II in renal function and nerve responses is not fully understood.
  • Investigating the differential effects of antioxidants and AT1 receptor antagonists on renal hemodynamics is crucial.

Purpose of the Study:

  • To compare the effects of tempol (antioxidant) and candesartan (AT1 receptor antagonist) on renal hemodynamics, excretory function, and renal nerve stimulation (RNS) responses.
  • To determine the contribution of superoxide to angiotensin II's actions on renal function and RNS responses in lean and obese rabbits.

Main Methods:

  • Comparison of tempol and candesartan administration in lean and obese rabbits under anesthesia.
  • Assessment of renal blood flow (RBF), glomerular filtration rate (GFR), and sodium excretion (U(Na)V).
  • Evaluation of responses to electrical stimulation of the renal nerves (RNS) and effects of drugs on these responses.

Main Results:

  • Candesartan increased RBF, while tempol reduced GFR and sodium excretion. Both drugs had similar depressor effects.
  • RNS reduced RBF, GFR, and U(Na)V. Candesartan blunted these RNS-induced reductions, while tempol only blunted the U(Na)V response.
  • Tempol did not alter RBF or GFR responses to RNS, unlike candesartan. Effects were similar in lean and obese rabbits.

Conclusions:

  • Tempol does not blunt RNS effects on renal hemodynamics, unlike candesartan, suggesting superoxide has a limited role in angiotensin II's actions on baseline renal function and RNS responses.
  • The study highlights distinct mechanisms of action for tempol and candesartan on renal hemodynamics and nerve responses.
  • Superoxide's contribution to endogenous angiotensin II's effects on renal hemodynamics and excretory function appears minimal under these experimental conditions.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...